Anyone who has had Covid-19 is invited to take part in a research project that aims to understand the experiences of people who had Covid-19 or were a probable case.
The COVID-19 Technical Advisory Group has recommended that people aged 12 and older who are severe immunocompromised receive a third primary dose of the Pfizer COVID-19 vaccine.